Off-shoring clinical research: exploitation and the reciprocity constraint.
The last 20 years have seen a staggering growth in the practice of off-shoring clinical research to low-and middle-income countries (LICs and MICs), a growth that has been matched by the neoliberal policies adopted by host countries towards attracting trials to their shores. A recurring concern in this context is the charge of exploitation, linked to various aspects of off-shoring. In this paper, I examine Alan Wertheimer's approach and offer an alternative view of understanding exploitation in this context. I will suggest that the justification for the enterprise of research is largely dependent on its integration within a health system from which participants regularly benefit and I argue that an attention to a principle of reciprocity will enable us to better recognize and address exploitation in international research.
University of Zurich.
Agomoni Ganguli
AG
Mitra
D035843:Biomedical Research / Q000941:ethics*; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000639:trends; D055812:Community-Based Participatory Research / Q000941:ethics / Q000639:trends; D003906:Developing Countries / Q000191:economics; D032984:Ethics, Research; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D020416:Outsourced Services / Q000941:ethics* / Q000639:trends; D011203:Poverty